Activation of the SPP1–CD44 axis between TAMs and cancer cells in localized regions within cancerous tissues subsequently triggers cancer-related signaling pathways, leading to exacerbation of the malignant phenotype in the related regions under locally selective pressures. The gene discussed is CD44; the disease is cancer.